BerGenBio
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
BGBIO | OL
Overview
Corporate Details
- ISIN(s):
- NO0012921180 (+2 more)
- LEI:
- 213800TYYFXKYF3V2A23
- Country:
- Norway
- Address:
- MØLLENDALSBAKKEN 9, 5009 BERGEN
- Website:
- https://www.bergenbio.com/
- Sector:
- Manufacturing
Description
BerGenBio was a clinical-stage biopharmaceutical company focused on developing first-in-class selective AXL kinase inhibitors. The company's therapeutic candidates targeted AXL as a potential cornerstone of therapy for aggressive, advanced, and treatment-resistant cancers. In October 2025, BerGenBio completed a merger with Oncoinvent ASA, and the combined entity was renamed Oncoinvent.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-09-11 05:00 |
BerGenBio to Present Company Update at H.C. Wainright Annual Global Investment …
|
English | 2.9 KB | ||
| 2023-08-27 18:35 |
Correction: BerGenBio ASA Seccond Quarter and half year 2023 Financial Report
|
English | 1.9 MB | ||
| 2023-08-27 18:35 |
Correction: BerGenBio ASA Seccond Quarter and half year 2023 Financial Report
|
English | 630 bytes | ||
| 2023-08-23 05:00 |
BerGenBio Reports Second Quarter 2023 Financial Results
|
English | 1.9 MB | ||
| 2023-08-23 05:00 |
BerGenBio Reports Second Quarter 2023 Financial Results
|
English | 14.3 KB | ||
| 2023-08-22 08:30 |
BerGenBio announces clinical data presentations highlighting the activity of it…
|
English | 3.7 KB | ||
| 2023-08-16 05:00 |
BerGenBio ASA: Invitation to second quarter and half year 2023 results webcast
|
English | 2.9 KB | ||
| 2023-06-29 12:39 |
BerGenBio ASA: Share capital increase registered
|
English | 2.4 KB | ||
| 2023-06-27 11:10 |
BerGenBio ASA: Resolution to increase the share capital for settlement of under…
|
English | 10.2 KB | ||
| 2023-06-23 05:00 |
BerGenBio ASA - Information about the Warrants issued in connection with the Ri…
|
English | 11.4 KB | ||
| 2023-06-22 10:36 |
BerGenBio ASA - Correction, new share capital and warrants registered
|
English | 2.5 KB | ||
| 2023-06-22 09:36 |
BerGenBio ASA - New share capital and warrants registered
|
English | 2.4 KB | ||
| 2023-06-22 05:00 |
BerGenBio Reports First Quarter 2023 Financial Results and Provides Business Up…
|
English | 1.7 MB | ||
| 2023-06-22 05:00 |
BerGenBio Reports First Quarter 2023 Financial Results and Provides Business Up…
|
English | 14.7 KB | ||
| 2023-06-19 14:40 |
BerGenBio ASA - Updated timeline for delivery of Offer Shares and Warrants in c…
|
English | 11.3 KB |
Automate Your Workflow. Get a real-time feed of all BerGenBio filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BerGenBio
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BerGenBio via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
